	Capital Y Las Reservas		Fecha
AbbVie	USD -2.64B	2.46B	2025-09
Amgen	USD 9.62B	2.19B	2025-09
Anika Therapeutics	USD 146.8M	867K	2025-09
Arrowhead Research	USD 568.42M	102.37M	2025-12
AstraZeneca	USD 45.89B	1.17B	2025-09
BioCryst Pharmaceuticals	USD -387.89M	33.7M	2025-09
Biogen	USD 18.21B	573.5M	2025-09
Bristol-Myers Squibb	USD 18.55B	1.06B	2025-09
Enanta Pharmaceuticals	USD 64.72M	14.56M	2025-09
Gilead Sciences	USD 21.46B	1.78B	2025-09
GlaxoSmithKline	GBP 16.38B	229M	2025-12
Halozyme Therapeutics	USD 503.92M	171.17M	2025-09
Heron Therapeutics	USD 14.88M	42.14M	2025-09
Immunic	USD 10.5M	23.41M	2025-09
Incyte	USD 5.17B	516.28M	2025-12
Insmed	USD 945.57M	304.16M	2025-09
Ionis Pharmaceuticals	USD 617.97M	13.76M	2025-09
J&J	USD 78.47B	0	2025-09
Karyopharm Therapeutics	USD -269.26M	30.33M	2025-09
Ligand Pharmaceuticals	USD 950.17M	121.64M	2025-09
Merck	USD 51.85B	2.79B	2025-09
Neurocrine Biosciences	USD 3B	309.3M	2025-09
Novartis	USD 44.75B	2.7B	2025-09
Novavax	USD -156.67M	194.3M	2025-09
Pfizer	USD 92.8B	4.11B	2025-09
PTC Therapeutics	USD -155.76M	50.79M	2025-09
Roche Holding	CHF 33.8B	758M	2025-12
Sarepta Therapeutics	USD 1.32B	37.26M	2025-09
Vertex Pharmaceuticals	USD 17.32B	143.4M	2025-09

Enanta Pharmaceuticals Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.